Toggle navigation
Home
Search
Services
Blog
Contact
About
Develop Emulsified Lipoid Contrast Media
Chatterji, Dulal
Quad Pharmaceuticals, Indianapolis, IN, United States
Search grants from Dulal Chatterji
Search grants from Quad Pharmaceuticals
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Regulation of Neutrophil Transcellular Migration'
Impact of Eliminating Extended Duration Work Shifts on Resident Health and Safety
Early Detection of Esophageal Cancer
Collaborative Proposal: Manufacturing of Nanocrystalline Bulk Materials by Field Activated Sintering
JGOFS: Carbon Flow Through The Microbial Loop in the Arabian Sea: Heterotrophic Nanoplankton Growth Rates and Picoplankton Grazing
Recently added grants:
Myocardial Radiomics and Mechanics in the Pathology and Prognosis of Cardiovascular Disease
Bio-tribo-corrosion resistant 3D Printed Composites for Load-bearing Implants
Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model
Expanding the known coding genome: identifying biological function for novel tORFs
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory Oncology
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067953-001
Application #
3614597
Study Section
Project Start
1986-09-30
Project End
Budget Start
1987-03-31
Budget End
1987-05-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Quad Pharmaceuticals
Department
Type
DUNS #
City
Indianapolis
State
IN
Country
United States
Zip Code
46268
Related projects
NIH 1987
N43 CM
Develop Emulsified Lipoid Contrast Media
Chatterji, Dulal / Quad Pharmaceuticals
NIH 1986
N43 CM
Develop Emulsified Lipoid Contrast Media
Chatterji, Dulal / Quad Pharmaceuticals
Comments
Be the first to comment on Dulal Chatterji's grant